Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
4.19B | 4.03B | 4.00B | 4.50B | 4.62B | 4.82B | Gross Profit |
1.34B | 1.25B | 1.16B | 1.17B | 1.16B | 1.33B | EBIT |
351.30M | 318.88M | 214.49M | 247.63M | 253.79M | 407.21M | EBITDA |
774.94M | 878.34M | 779.70M | 845.67M | 873.46M | 842.34M | Net Income Common Stockholders |
146.02M | 153.37M | 69.12M | 42.83M | 97.51M | 75.81M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.10B | 1.10B | 1.01B | 1.25B | 1.50B | 1.33B | Total Assets |
20.35B | 20.35B | 20.43B | 21.11B | 21.91B | 22.37B | Total Debt |
10.04B | 10.02B | 10.48B | 10.92B | 11.55B | 12.18B | Net Debt |
8.95B | 8.95B | 9.47B | 9.67B | 10.06B | 10.85B | Total Liabilities |
15.41B | 15.41B | 15.64B | 16.47B | 17.29B | 17.95B | Stockholders Equity |
4.94B | 4.94B | 4.79B | 4.65B | 4.62B | 4.42B |
Cash Flow | Free Cash Flow | ||||
0.00 | 693.05M | 159.35M | 388.99M | 820.70M | -1.79B | Operating Cash Flow |
0.00 | 757.99M | 367.94M | 516.95M | 899.39M | 283.57M | Investing Cash Flow |
0.00 | -54.90M | -187.53M | -127.97M | -64.58M | -2.08B | Financing Cash Flow |
0.00 | -616.48M | -422.96M | -632.77M | -668.65M | 1.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥27.48B | 21.00 | 4.61% | -9.16% | -42.30% | ||
68 Neutral | ¥2.92B | 9.10 | 2.78% | 8.57% | 140.21% | ||
66 Neutral | ¥3.73B | 5.39 | 3.48% | 4.98% | 332.47% | ||
62 Neutral | $6.93B | 11.25 | 2.95% | 3.88% | 2.69% | -24.71% | |
57 Neutral | ¥3.12B | 56.31 | 2.91% | 1.81% | -63.86% | ||
56 Neutral | ¥1.95B | 6.44 | ― | 12.55% | ― | ||
53 Neutral | ¥24.53B | 20.34 | 10.48% | -0.31% | -853.48% |